Vaxil Bio Ltd. (VXL.V) TSXV

0.13

+0(+0.00%)

Updated at January 14 09:07AM

Currency In CAD

Valuation

Market Cap28.08M
Enterprise Value27.63M
P/E Ratio-5.09
PEG Ratio0.1
Price/Sales Ratio0
Price/Book Ratio0.53
Enterprise/Revenue0
Enterprise/EBITDA0.55

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.1

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-178,000
Net Income-178,000
Diluted EPS-0

Balance Sheet

Total Cash447,000
Total Cash/Share0.16
Total Debt0
Total Debt/Equity0
Current Ratio75.38
Book Value Per Share0.24

Price History

52-Week Change-36.59
52-Week High0.5
52-Week Low0.01
Moving Average 50 Days0.14
Moving Average 200 Days0.18

Statistics

Average Volume2,234
Shares Outstanding2.74M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 15, 2025